Aspire Biopharma Holdings Inc. completed its $30 million acquisition of Dura Driver Control Systems, expanding the biopharmaceutical company into the automotive and mobility-control market. The deal gives Aspire 100% ownership of DCS, a tier-one automotive supplier of electronic driver controls, which is now a wholly owned subsidiary. Aspire paid about $30 million in cash and also entered into a $22.5 million senior secured revolving credit facility to help finance the transaction. DCS generated $209.5 million in audited revenue and $22.3 million in adjusted EBITDA in 2025, and for the first six months of 2026 it posted unaudited revenue of about $103.9 million and adjusted EBITDA of $10.5 million. CEO Kraig Higginson said the acquisition is a cash-flow-positive milestone that structurally enhances Aspire's valuation and adds high-volume revenue streams.
Aspire BioPharma, Inc.Completed $30M acquisition of Dura Driver Control Systems, adding high-volume revenue and enhancing valuation.
